KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Non-Current Deffered Revenue (2019)

Historic Non-Current Deffered Revenue for Xenon Pharmaceuticals (XENE) over the last 4 years, with Q4 2019 value amounting to $709000.0.

  • Xenon Pharmaceuticals' Non-Current Deffered Revenue changed N/A to $709000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $709000.0, marking a year-over-year change of. This contributed to the annual value of $709000.0 for FY2019, which is N/A changed from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Non-Current Deffered Revenue of $709000.0 as of Q4 2019.
  • In the past 5 years, Xenon Pharmaceuticals' Non-Current Deffered Revenue registered a high of $709000.0 during Q4 2019, and its lowest value of $164000.0 during Q2 2015.